Sarkar, S., Kumari, D., Gupta, S. K., Sharma, V., Mukhi, S., Kamboj, P., . . . Dikshit, M. (2021). Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. Elsevier.
Style de citation Chicago (17e éd.)Sarkar, Soumalya, et al. Saroglitazar and Hepano Treatment Offers Protection Against High Fat High Fructose Diet Induced Obesity, Insulin Resistance and Steatosis by Modulating Various Class of Hepatic and Circulating Lipids. Elsevier, 2021.
Style de citation MLA (8e éd.)Sarkar, Soumalya, et al. Saroglitazar and Hepano Treatment Offers Protection Against High Fat High Fructose Diet Induced Obesity, Insulin Resistance and Steatosis by Modulating Various Class of Hepatic and Circulating Lipids. Elsevier, 2021.